Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study.
Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient.
The Influence of T Cell Ig Mucin-3 Signaling on Central Nervous System Autoimmune Disease Is Determined by the Effector Function of the Pathogenic T Cells.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.
Partnering to Increase Access to Community Exercise Programs for People With Stroke, Acquired Brain Injury and Multiple Sclerosis.
BG-12 in Multiple Sclerosis.
Teaching NeuroImages: Neuromyelitis optica misdiagnosed as spinal cord tumor.
Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules.
Cognitive Impairments in Multiple SclerosisImplications for Rehabilitation.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis.
Increased expression of Aquaporin 4 in the rat hippocampus and cortex during trimethyltin-induced neurodegeneration.
Biomarkers of interferon Beta therapy in multiple sclerosis.
Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India.
Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.
Managing patients with neurologic disorders who participate in sports activities.
Fingolimod for the treatment of neurological diseases-state of play and future perspectives.
Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.
Varicella-zoster virus encephalomyelitis with a prominent demyelinating component.
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry.
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.
B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Pages
« first
‹ previous
…
459
460
461
462
463
464
465
466
467
…
next ›
last »